24-27 November 2026
Crocus Expo, Pavilion 2, Eurasia
Wecare Probiotics: Driving Innovation in Probiotic Raw Materials and Clinical Research
Published on: Nov 18, 2025
Reading Time: 5 min
Wecare Probiotics is one of China’s leading probiotic raw material manufacturers, delivering high-quality, science-backed solutions for the global nutrition, health, and functional food industries. With over 40,000 microbial resources, more than 300 patents, and exports to over 80 countries, Wecare has established itself as a trusted partner for brands worldwide.
Our mission is to harness the power of beneficial microbes to improve human health and well-being. Through continuous investment in R&D, advanced manufacturing, and global regulatory expertise, Wecare supports the full value chain—from strain discovery and functional evaluation to pilot scale, intelligent manufacturing, and commercial applications.
Latest Clinical Breakthroughs
In 2025, Wecare’s flagship strain Weizmannia coagulans BC99 achieved global recognition by winning the NutraIngredients Awards, Ingredient of the Year in both Asia and Europe. This milestone marked the first time a Bacillus coagulans strain from China won dual international awards, highlighting its strong clinical validation and global competitiveness.
BC99 has demonstrated clear benefits in digestive health, immunity, and metabolic support, with recent clinical studies confirming its applications in weight management and functional foods. Its exceptional stability and survivability across capsules, powders, gummies, dairy, and beverages ensure it meets the diverse needs of modern consumers.
Expanding a Science-Driven Portfolio
Beyond BC99, Wecare Probiotics offers a wide range of clinically studied strains under the WecLac® portfolio, including Bifidobacterium animalis BLa80, Lacticaseibacillus rhamnosus LRa05, Akkermansia muciniphila Akk11, and Bifidobacterium longum subsp. longum BL21.
We also provide WecMix™ customised probiotic blends and WecPost™ postbiotic strains, supporting applications in:
- Digestive and gastrointestinal health
- Immune system support
- Sports and active nutrition
- Women’s health and maternal care
- Skin, oral, and mental health
Global Reach and Intelligent Manufacturing
With an annual production capacity exceeding 1,000 metric tons, Wecare operates intelligent manufacturing facilities equipped with rigorous quality systems that meet global GMP standards. Our commitment to sustainability, transparency, and technological excellence enables us to serve partners across Europe, North America, and Asia-Pacific with consistency and confidence.
Looking Ahead
As demand for preventive health and microbiome-based solutions accelerates, Wecare Probiotics remains committed to advancing clinical research, expanding functional applications, and building long-term partnerships. From next-generation strains like Akkermansia Akk11 to innovative postbiotic technologies, we continue to push the boundaries of probiotic science.